FDA Webview
X
Search
Log In
Home
About Us
Today@FDA
Pay Per View
Free Trial
Contact Us
More
▼
Tell Friend
Subscribe
Free FDA Notices
Comments Sought on Premarket Notification
11/03/2006
Federal Register
Notice: FDA is seeking comment on the proposed collection of certain information, "Premarket Notification — 21 CFR Part 807; Subpart E." Comments should be submitted by 1/2/07. To view this notice, click
here
.
Categories
Animal Drugs
Biologics
FDA General
Federal Register
Human Drugs
Marketing
Medical Devices
Top News
Tvardis Lung Disease Drug Falls Short in Trial
Regeneron Gene Therapy Improved Rare Hearing Loss
FDA Approves Celltrions Eylea Biosimilar
Cybersecurity Alert on Abiomed Impella Controllers
FDA Updates Carvykti Labeling With Boxed Warning
SQ Innovation Gets Edema At-Home Treatment OKd
GOP Senators Call on FDA to Restrict Generic Mifepristone
Glioblastoma Multiforme Drug Gets Orphan Status
LATEST NEWS
Read More
Human Drugs
Tvardis Lung Disease Drug Falls Short in Trial
Read More
Biologics
Regeneron Gene Therapy Improved Rare Hearing Loss
Read More
Biologics
FDA Approves Celltrions Eylea Biosimilar
Read More
Medical Devices
Cybersecurity Alert on Abiomed Impella Controllers
FDA Webview Free Daily e-Newsletter
Free Sign-Up
